Search Results

You are looking at 1 - 10 of 92 items for :

  • randomised clinical trial x
Clear All
Open access

Stan Ursem, Vito Francic, Martin Keppel, Verena Schwetz, Christian Trummer, Marlene Pandis, Felix Aberer, Martin R Grübler, Nicolas D Verheyen, Winfried März, Andreas Tomaschitz, Stefan Pilz, Barbara Obermayer-Pietsch and Annemieke C Heijboer

vitamin D supplementation on the n-oxPTH concentrations in comparison to tPTH in a population with normal renal function. For this purpose, we measured n-oxPTH in the Styrian Hypertension Study, a vitamin D randomised controlled trial ( 14 ). In addition

Open access

Nikolaj Rittig, Mads Svart, Niels Jessen, Niels Møller, Holger J Møller and Henning Grønbæk

randomise interventions. Four of the test subjects received LPS during their first trial followed by placebo during their second trial and the other four test subjects received placebo first followed by LPS. During each trial, intravenous catheters were

Open access

Cecilia Lundin, Agota Malmborg, Julia Slezak, Kristina Gemzell Danielsson, Marie Bixo, Hanna Bengtsdotter, Lena Marions, Ingela Lindh, Elvar Theodorsson, Mats Hammar and Inger Sundström-Poromaa

, EPN 2013/161 Uppsala, and the Medical Products Agency in Sweden and was pre-registered: EUDRA-CT 2013-000925-30. Study design The study was a double-blind, randomised, parallel-group clinical trial during which the participants were treated

Open access

Line K Johnson, Kirsten B Holven, Njord Nordstrand, Jan R Mellembakken, Tom Tanbo and Jøran Hjelmesæth

composition, gastrointestinal symptoms and hormonal characteristics of PCOS. Subjects and methods Study design, population and setting Parallel-group randomised controlled clinical trial (allocation ratio 1:1) of 18–40 years old treatment seeking morbidly

Open access

Karoline Winckler, Lise Tarnow, Louise Lundby-Christensen, Thomas P Almdal, Niels Wiinberg, Pia Eiken, Trine W Boesgaard and the CIMT trial group

relationship between 25(OH)D, risk of CVD (measured as carotid IMT, carotid artery DC and YEM) and bone health (measured as BMD and trabecular bone score (TBS)) in a Danish cohort of patients with T2D participating in a randomised clinical trial (The Copenhagen

Open access

S Westra, Y H M Krul-Poel, H J van Wijland, M M ter Wee, F Stam, P Lips, F Pouwer and S Simsek

be of value in the clinical setting. In addition, the only randomised placebo-controlled trial in this review with the maximal points for methodology, found no effect of vitamin D supplementation (daily oral 800 IU vitamin D3) on the physical

Open access

Richard H Tuligenga

been inconclusive (12) . Recent randomised controlled trials (RCTs) show that intensive glycaemic control does not have beneficial effects on the rate of cognitive decline (13, 14, 15, 16) . The increased frequency of hypoglycaemia in patients treated

Open access

Yongli Fu, Yaowu Sun, Jiankun Zhang and Yu Cheng

glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial . Critical Care 2008 12 R120 . ( ) 36 Brunkhorst FM Engel C Bloos F Meier-Hellmann A Ragaller

Open access

Michael Ulm, Arvind V Ramesh, Keely M McNamara, Suriyan Ponnusamy, Hironobu Sasano and Ramesh Narayanan

finasteride inhibits types 2 and 3, resulting in a 70% inhibition of DHT synthesis, dutasteride inhibits all three isoforms and thereby provides a complete inhibition of DHT synthesis ( 16 ). Two clinical trials, one with finasteride (Prostate Cancer

Open access

Anna Olsson-Brown, Rosemary Lord, Joseph Sacco, Jonathan Wagg, Mark Coles and Munir Pirmohamed

hypothyroidism and de novo development of hypothyroidism. We also showed an association with gender and variable presence of autoantibodies. A recent systematic review of 38 randomised clinical trials showed that the risk of thyroid dysfunction was highest with